SciSparc announced that it has engaged Rosario Capital Ltd., one of Israel’ leading investment banks, to identify potential opportunities for a strategic transaction. Rosario Capital will seek and evaluate potential strategic transactions on behalf of the Company, including additional investments in innovative companies, a strategic partnership with one or more parties, or the licensing of one or more of the Company’s proprietary technologies or indications. Pending any decision to undertake any such strategic transaction, the Company will continue its development activities in accordance with its existing business strategy.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SPRC:
- SciSparc Engages Investment Bank to Identify Potential Strategic Transaction Opportunities
- SciSparc initiates Phase 2b trial of Tourette Syndrome dandidate SCI-110
- SciSparc Announces Initiation of Randomized Phase IIb Clinical Trial of its Proprietary SCI-110 for Tourette Syndrome
- SciSparc granted 180-day extension by Nasdaq to regain compliance
- SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement